State of the Science Evaluation - June 4, 2016

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	0
Discuss and compare clinical and technical approaches to high flow nasal cannula, continuous positive airway pressure and noninvasive ventilation.	Discuss and compare clinical and technical approaches to high flow nasal cannula, continuous positive airway pressure and noninvasive ventilation. - 5	Discuss and compare clinical and technical approaches to high flow nasal cannula, continuous positive airway pressure and noninvasive ventilation. - 4	Discuss and compare clinical and technical approaches to high flow nasal cannula, continuous positive airway pressure and noninvasive ventilation. - 3	Discuss and compare clinical and technical approaches to high flow nasal cannula, continuous positive airway pressure and noninvasive ventilation. - 2	Discuss and compare clinical and technical approaches to high flow nasal cannula, continuous positive airway pressure and noninvasive ventilation. - 1	Discuss and compare clinical and technical approaches to high flow nasal cannula, continuous positive airway pressure and noninvasive ventilation. - 0
Discuss the physiologic rationale for setting Positive End Expiratory Pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS).	Discuss the physiologic rationale for setting Positive End Expiratory Pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS). - 5	Discuss the physiologic rationale for setting Positive End Expiratory Pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS). - 4	Discuss the physiologic rationale for setting Positive End Expiratory Pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS). - 3	Discuss the physiologic rationale for setting Positive End Expiratory Pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS). - 2	Discuss the physiologic rationale for setting Positive End Expiratory Pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS). - 1	Discuss the physiologic rationale for setting Positive End Expiratory Pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS). - 0
Describe approaches to PEEP titration in patients with ARDS.	Describe approaches to PEEP titration in patients with ARDS. - 5	Describe approaches to PEEP titration in patients with ARDS. - 4	Describe approaches to PEEP titration in patients with ARDS. - 3	Describe approaches to PEEP titration in patients with ARDS. - 2	Describe approaches to PEEP titration in patients with ARDS. - 1	Describe approaches to PEEP titration in patients with ARDS. - 0
Explain non-ARDS application for PEEP.	Explain non-ARDS application for PEEP. - 5	Explain non-ARDS application for PEEP. - 4	Explain non-ARDS application for PEEP. - 3	Explain non-ARDS application for PEEP. - 2	Explain non-ARDS application for PEEP. - 1	Explain non-ARDS application for PEEP. - 0
List and define the criteria for sepsis and septic shock in Sepsis-3	List and define the criteria for sepsis and septic shock in Sepsis-3 - 5	List and define the criteria for sepsis and septic shock in Sepsis-3 - 4	List and define the criteria for sepsis and septic shock in Sepsis-3 - 3	List and define the criteria for sepsis and septic shock in Sepsis-3 - 2	List and define the criteria for sepsis and septic shock in Sepsis-3 - 1	List and define the criteria for sepsis and septic shock in Sepsis-3 - 0
Implement treatment plans quickly when managing Sepsis-3.	Implement treatment plans quickly when managing Sepsis-3. - 5	Implement treatment plans quickly when managing Sepsis-3. - 4	Implement treatment plans quickly when managing Sepsis-3. - 3	Implement treatment plans quickly when managing Sepsis-3. - 2	Implement treatment plans quickly when managing Sepsis-3. - 1	Implement treatment plans quickly when managing Sepsis-3. - 0
Compare Sepsis-3 to criteria for sepsis quality improvement, surveillance and research.	Compare Sepsis-3 to criteria for sepsis quality improvement, surveillance and research. - 5	Compare Sepsis-3 to criteria for sepsis quality improvement, surveillance and research. - 4	Compare Sepsis-3 to criteria for sepsis quality improvement, surveillance and research. - 3	Compare Sepsis-3 to criteria for sepsis quality improvement, surveillance and research. - 2	Compare Sepsis-3 to criteria for sepsis quality improvement, surveillance and research. - 1	Compare Sepsis-3 to criteria for sepsis quality improvement, surveillance and research. - 0
Examine the studies that led to “The Surviving Sepsis Campaign” international guidelines for the management of patients with sepsis and septic shock.	Examine the studies that led to “The Surviving Sepsis Campaign” international guidelines for the management of patients with sepsis and septic shock. - 5	Examine the studies that led to “The Surviving Sepsis Campaign” international guidelines for the management of patients with sepsis and septic shock. - 4	Examine the studies that led to “The Surviving Sepsis Campaign” international guidelines for the management of patients with sepsis and septic shock. - 3	Examine the studies that led to “The Surviving Sepsis Campaign” international guidelines for the management of patients with sepsis and septic shock. - 2	Examine the studies that led to “The Surviving Sepsis Campaign” international guidelines for the management of patients with sepsis and septic shock. - 1	Examine the studies that led to “The Surviving Sepsis Campaign” international guidelines for the management of patients with sepsis and septic shock. - 0
Implement innovative strategies to improve patient outcomes.	Implement innovative strategies to improve patient outcomes. - 5	Implement innovative strategies to improve patient outcomes. - 4	Implement innovative strategies to improve patient outcomes. - 3	Implement innovative strategies to improve patient outcomes. - 2	Implement innovative strategies to improve patient outcomes. - 1	Implement innovative strategies to improve patient outcomes. - 0
Recognize barriers to the implementation of appropriate sepsis protocols, and employ evidence-based solutions.	Recognize barriers to the implementation of appropriate sepsis protocols, and employ evidence-based solutions. - 5	Recognize barriers to the implementation of appropriate sepsis protocols, and employ evidence-based solutions. - 4	Recognize barriers to the implementation of appropriate sepsis protocols, and employ evidence-based solutions. - 3	Recognize barriers to the implementation of appropriate sepsis protocols, and employ evidence-based solutions. - 2	Recognize barriers to the implementation of appropriate sepsis protocols, and employ evidence-based solutions. - 1	Recognize barriers to the implementation of appropriate sepsis protocols, and employ evidence-based solutions. - 0
Explain the future of sepsis management strategies.	Explain the future of sepsis management strategies. - 5	Explain the future of sepsis management strategies. - 4	Explain the future of sepsis management strategies. - 3	Explain the future of sepsis management strategies. - 2	Explain the future of sepsis management strategies. - 1	Explain the future of sepsis management strategies. - 0
Identify the risks for patients with new psychiatric illness and medication use after critical care.	Identify the risks for patients with new psychiatric illness and medication use after critical care. - 5	Identify the risks for patients with new psychiatric illness and medication use after critical care. - 4	Identify the risks for patients with new psychiatric illness and medication use after critical care. - 3	Identify the risks for patients with new psychiatric illness and medication use after critical care. - 2	Identify the risks for patients with new psychiatric illness and medication use after critical care. - 1	Identify the risks for patients with new psychiatric illness and medication use after critical care. - 0
Implement potential risk-reducing strategies for psychiatric illnesses in critical care.	Implement potential risk-reducing strategies for psychiatric illnesses in critical care. - 5	Implement potential risk-reducing strategies for psychiatric illnesses in critical care. - 4	Implement potential risk-reducing strategies for psychiatric illnesses in critical care. - 3	Implement potential risk-reducing strategies for psychiatric illnesses in critical care. - 2	Implement potential risk-reducing strategies for psychiatric illnesses in critical care. - 1	Implement potential risk-reducing strategies for psychiatric illnesses in critical care. - 0
Assess the range of palliative care needs of ICU patients.	Assess the range of palliative care needs of ICU patients. - 5	Assess the range of palliative care needs of ICU patients. - 4	Assess the range of palliative care needs of ICU patients. - 3	Assess the range of palliative care needs of ICU patients. - 2	Assess the range of palliative care needs of ICU patients. - 1	Assess the range of palliative care needs of ICU patients. - 0
Identify the utility of specific triggers for palliative care consultations.	Identify the utility of specific triggers for palliative care consultations. - 5	Identify the utility of specific triggers for palliative care consultations. - 4	Identify the utility of specific triggers for palliative care consultations. - 3	Identify the utility of specific triggers for palliative care consultations. - 2	Identify the utility of specific triggers for palliative care consultations. - 1	Identify the utility of specific triggers for palliative care consultations. - 0
Describe the role of procoagulants in life-threatening bleeding.	Describe the role of procoagulants in life-threatening bleeding. - 5	Describe the role of procoagulants in life-threatening bleeding. - 4	Describe the role of procoagulants in life-threatening bleeding. - 3	Describe the role of procoagulants in life-threatening bleeding. - 2	Describe the role of procoagulants in life-threatening bleeding. - 1	Describe the role of procoagulants in life-threatening bleeding. - 0
List and explain studies of recombinant factor VIIa.	List and explain studies of recombinant factor VIIa. - 5	List and explain studies of recombinant factor VIIa. - 4	List and explain studies of recombinant factor VIIa. - 3	List and explain studies of recombinant factor VIIa. - 2	List and explain studies of recombinant factor VIIa. - 1	List and explain studies of recombinant factor VIIa. - 0
Explain how to manage life threatening bleeding and treat an emergency procedure in patients receiving anticoagulants	Explain how to manage life threatening bleeding and treat an emergency procedure in patients receiving anticoagulants - 5	Explain how to manage life threatening bleeding and treat an emergency procedure in patients receiving anticoagulants - 4	Explain how to manage life threatening bleeding and treat an emergency procedure in patients receiving anticoagulants - 3	Explain how to manage life threatening bleeding and treat an emergency procedure in patients receiving anticoagulants - 2	Explain how to manage life threatening bleeding and treat an emergency procedure in patients receiving anticoagulants - 1	Explain how to manage life threatening bleeding and treat an emergency procedure in patients receiving anticoagulants - 0

Rate the following *

Scoring Key: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor

	5	4	3	2	1
Christopher W. Seymour, M.D. - Sepsis 3: Confusion or Clarity?	Christopher W. Seymour, M.D. - Sepsis 3: Confusion or Clarity? - 5	Christopher W. Seymour, M.D. - Sepsis 3: Confusion or Clarity? - 4	Christopher W. Seymour, M.D. - Sepsis 3: Confusion or Clarity? - 3	Christopher W. Seymour, M.D. - Sepsis 3: Confusion or Clarity? - 2	Christopher W. Seymour, M.D. - Sepsis 3: Confusion or Clarity? - 1
Dean R. Hess, Ph.D., RRT - Noninvasive Respiratory Support	Dean R. Hess, Ph.D., RRT - Noninvasive Respiratory Support - 5	Dean R. Hess, Ph.D., RRT - Noninvasive Respiratory Support - 4	Dean R. Hess, Ph.D., RRT - Noninvasive Respiratory Support - 3	Dean R. Hess, Ph.D., RRT - Noninvasive Respiratory Support - 2	Dean R. Hess, Ph.D., RRT - Noninvasive Respiratory Support - 1
Hannah Wunsch, M.D. - Identifying Palliative Care needs in The ICU	Hannah Wunsch, M.D. - Identifying Palliative Care needs in The ICU - 5	Hannah Wunsch, M.D. - Identifying Palliative Care needs in The ICU - 4	Hannah Wunsch, M.D. - Identifying Palliative Care needs in The ICU - 3	Hannah Wunsch, M.D. - Identifying Palliative Care needs in The ICU - 2	Hannah Wunsch, M.D. - Identifying Palliative Care needs in The ICU - 1
Steven Fein, M.D. - Managing Life Threatening Bleeding with Procoagulants and Anticoagulant Reversal	Steven Fein, M.D. - Managing Life Threatening Bleeding with Procoagulants and Anticoagulant Reversal - 5	Steven Fein, M.D. - Managing Life Threatening Bleeding with Procoagulants and Anticoagulant Reversal - 4	Steven Fein, M.D. - Managing Life Threatening Bleeding with Procoagulants and Anticoagulant Reversal - 3	Steven Fein, M.D. - Managing Life Threatening Bleeding with Procoagulants and Anticoagulant Reversal - 2	Steven Fein, M.D. - Managing Life Threatening Bleeding with Procoagulants and Anticoagulant Reversal - 1
Dean R. Hess, Ph.D., RRT - How to set PEEP	Dean R. Hess, Ph.D., RRT - How to set PEEP - 5	Dean R. Hess, Ph.D., RRT - How to set PEEP - 4	Dean R. Hess, Ph.D., RRT - How to set PEEP - 3	Dean R. Hess, Ph.D., RRT - How to set PEEP - 2	Dean R. Hess, Ph.D., RRT - How to set PEEP - 1
Hannah Wunsch, M.D. - Psychiatric Diagnosis and Medications After Critical Illness	Hannah Wunsch, M.D. - Psychiatric Diagnosis and Medications After Critical Illness - 5	Hannah Wunsch, M.D. - Psychiatric Diagnosis and Medications After Critical Illness - 4	Hannah Wunsch, M.D. - Psychiatric Diagnosis and Medications After Critical Illness - 3	Hannah Wunsch, M.D. - Psychiatric Diagnosis and Medications After Critical Illness - 2	Hannah Wunsch, M.D. - Psychiatric Diagnosis and Medications After Critical Illness - 1
Christopher W. Seymour, M.D. - Surviving Sepsis Update	Christopher W. Seymour, M.D. - Surviving Sepsis Update - 5	Christopher W. Seymour, M.D. - Surviving Sepsis Update - 4	Christopher W. Seymour, M.D. - Surviving Sepsis Update - 3	Christopher W. Seymour, M.D. - Surviving Sepsis Update - 2	Christopher W. Seymour, M.D. - Surviving Sepsis Update - 1

Was this course fair, balanced and without commercial bias? *

Yes

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so. *

Comments

Leave this field blank

You are here

State of the Science Evaluation - June 4, 2016